With plenty of hazardous sites still to be cleaned up,analysts call biological disposal of wastes afield with a bright future Amid the doom and gloom of the job outlook for United States researchers, employment analysts are pointing to the environmental services market as one bright spot for candidates with scientific training. A recent U.S. News & World Report employment guide lists "environmental manager" as one of the top-20 "hot job tracks." According to the magazine, government and indus
With plenty of hazardous sites still to be cleaned up,analysts call biological disposal of wastes afield with a bright future |
Industry observers say that within this fast-growing business, life scientists--including biochemists and microbiologists-- would do well to seek out the small but rapidly expanding segment of bioremediation for employment. According to some estimates, market revenue in this field has at least doubled over the last five years.
Type of Company ...
Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.
View this Issue
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.
Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement.
Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.
Tailored nucleic acid extraction and amplification methods help scientists overcome the challenges of detecting Mycoplasma contamination in advanced therapy medicinal products.
